Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

ASP Isotopes Inc. (ASPI) Financial Statements

ASP Isotopes Inc. (ASPI) reported trailing twelve-month revenue of $30.9M (up 573.4% year on year) and net income of -$117.3M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$83.6M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ASPIASP Isotopes Inc.Follow ASPI — free
Chemicals · Basic Materials
—
Price chart with a free account
Market cap
298.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue0.44.123.830.9
Gross profit0.11.63.45.7
Research & development0.83.112.422.0
Operating income-16.0-26.4-59.9-99.1
Pre-tax income-16.3-32.3-159.6-136.8
Income tax-0.00.10.30.1
Net income-16.3-32.4-159.8-117.3
Diluted EPS ($)—-0.63-2.11-1.08
Diluted shares (mn)—55.783.0—

USD millions · SEC XBRL

ASP Isotopes Inc. — questions

What is ASP Isotopes Inc.'s revenue?
$30.9M over the twelve months to 2026-06-30, up 573.4% year on year, from its 10-Q and 10-K filings.
What is ASP Isotopes Inc.'s net income?
-$117.3M over the twelve months to 2026-06-30.
What is ASP Isotopes Inc.'s free cash flow?
-$83.6M over the twelve months to 2026-06-30.
What are ASP Isotopes Inc.'s diluted earnings per share?
$-1.08 over the twelve months to 2026-06-30.

Every figure on this page comes from ASP Isotopes Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.